How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Ricky Mulvey: One of the ways that the drug makers are trying to innovate is by introducing more weight loss pills. We've been talking about injections so far. But Eli Lilly right now has $550 ...

Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...

After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...

but Eli Lilly is in hot pursuit. The 50 mg oral semaglutide pill achieved a 15.1% weight loss in the phase 3 OASIS study involving patients who were overweight or obese, but who did not have ...

and also claim that its current Ozempic shows the greater levels of blood sugar and weight reduction when compared with Bydureon and Eli Lilly’s Trulicity. Market analysts suggest that Novo ...

Eli Lilly plans to launch Mounjaro, its blockbuster diabetes drug, in countries like China, India, Brazil and Mexico by 2026, ...

Roche moved to enter the booming weight-loss drug market now dominated by Novo Nordisk and Eli Lilly. The Swiss ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...